In recent years, the biotechnology sector has undergone a transformation powered not only by cutting-edge scientific breakthroughs but also by a new class of supporters—small investors. While institutional funding still plays a major role, the democratization of investment platforms and growing public interest in life sciences have given everyday investors a chance to participate...